BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 8679458)

  • 1. An analysis of surveillance for stage I combined teratoma--seminoma of the testis.
    Thomas R; Dearnaley D; Nicholls J; Norman A; Sampson S; Horwich A
    Br J Cancer; 1996 Jul; 74(1):59-62. PubMed ID: 8679458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is surveillance for stage 1 germ cell tumours of the testis appropriate outside a specialist centre?
    Jones A; Fergus JN; Chapman J; Houghton L
    BJU Int; 1999 Jul; 84(1):79-84. PubMed ID: 10444129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of clinical stage I testicular pure seminoma. Report on 42 patients and review of the literature.
    Porcaro AB; Antoniolli SZ; Schiavone D; Maffei N; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):77-80. PubMed ID: 12161941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncological outcomes in patients with stage I testicular seminoma and nonseminoma: pathological risk factors for relapse and feasibility of surveillance after orchiectomy.
    Kobayashi K; Saito T; Kitamura Y; Nobushita T; Kawasaki T; Hara N; Takahashi K
    Diagn Pathol; 2013 Apr; 8():57. PubMed ID: 23566361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ-cell tumour: results from a 17-year UK experience.
    Chau C; Cathomas R; Wheater M; Klingbiel D; Fehr M; Bennett J; Markham H; Lee C; Crabb SJ; Geldart T
    Ann Oncol; 2015 Sep; 26(9):1865-1870. PubMed ID: 26037797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
    Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Characteristics and Outcomes of Late Relapse in Stage I Testicular Seminoma.
    Hosni A; Warde P; Jewett M; Bedard P; Hamilton R; Moore M; Nayan M; Huang R; Atenafu EG; O'Malley M; Sweet J; Chung P
    Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):648-54. PubMed ID: 27339401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance for stage I testicular germ cell tumours: results and cost benefit analysis of management options.
    Francis R; Bower M; Brunström G; Holden L; Newlands ES; Rustin GJ; Seckl MJ
    Eur J Cancer; 2000 Oct; 36(15):1925-32. PubMed ID: 11000572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance in stage I testicular seminoma - risk of late relapse.
    Chung P; Parker C; Panzarella T; Gospodarowicz MK; Jewett S; Milosevic MF; Catton CN; Bayley AJ; Tew-George B; Moore M; Sturgeon JF; Warde P
    Can J Urol; 2002 Oct; 9(5):1637-40. PubMed ID: 12431325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of stage I testicular seminoma over a period of 49 years.
    Detti B; Scoccianti S; Villari D; Cipressi S; Sardaro A; Simontacchi G; Livi L; Gacci M; Cai T; Greto D; Desideri I; Biti G
    Onkologie; 2011; 34(10):510-4. PubMed ID: 21985849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in adjuvant therapy utilization in stage I seminoma: are they enough to prevent overtreatment?
    Kohut RM; Minnillo BJ; Kypriotakis G; Abouassaly R; Zhu H
    Urology; 2014 Dec; 84(6):1319-24. PubMed ID: 25432823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).
    Rothermundt C; Thurneysen C; Cathomas R; Müller B; Mingrone W; Hirschi-Blickenstorfer A; Wehrhahn T; Ruf C; Rothschild S; Seifert B; Terbuch A; Grassmugg T; Woelky R; Fankhauser C; Kunit T; Fischer N; Inauen R; Kamradt J; Ziegler K; Haynes A; Jüni P; Gillessen S
    Swiss Med Wkly; 2018; 148():w14640. PubMed ID: 30044478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study group.
    Tandstad T; Smaaland R; Solberg A; Bremnes RM; Langberg CW; Laurell A; Stierner UK; Ståhl O; Cavallin-Ståhl EK; Klepp OH; Dahl O; Cohn-Cedermark G
    J Clin Oncol; 2011 Feb; 29(6):719-25. PubMed ID: 21205748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance in stage I testicular seminoma.
    Chung P; Warde P
    Urol Oncol; 2006; 24(1):75-9. PubMed ID: 16414499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observation versus adjuvant radiation or chemotherapy in the management of stage I seminoma: clinical outcomes and prognostic factors for relapse in a large US cohort.
    Soper MS; Hastings JR; Cosmatos HA; Slezak JM; Wang R; Lodin K
    Am J Clin Oncol; 2014 Aug; 37(4):356-9. PubMed ID: 23275274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of care in the management of seminoma stage I: results from a European survey.
    Vossen CY; Horwich A; Daugaard G; van Poppel H; Osanto S
    BJU Int; 2012 Aug; 110(4):524-31. PubMed ID: 22409585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant radiation therapy in stage I seminoma: 20 years of oncologic results.
    De Felice F; Musio D; Gravina GL; Marampon F; Tombolini V
    Oncotarget; 2016 Nov; 7(48):80077-80082. PubMed ID: 27556300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late Relapse of Nonseminomatous Germ Cell Tumor 24 Years Later.
    Riedinger CB; Labbate C; Werntz RP; Eggener SE
    Urology; 2018 Dec; 122():16-18. PubMed ID: 30170087
    [No Abstract]   [Full Text] [Related]  

  • 20. Exploration of treatment options for the management of stage I testicular seminoma.
    Bernal F; Raman JD
    Expert Rev Anticancer Ther; 2008 Jul; 8(7):1081-90. PubMed ID: 18588453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.